Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Prostanoid IP antagonists and their use in bladder disorders reported by Roche

Nov. 6, 2002

Tadalafil reported safe and effective in broad-spectrum erectile dysfunction

Nov. 5, 2002

TAP Pharmaceutical submits NDA for Uprima for ED

Nov. 4, 2002

Promising laboratory results for phosphate-lowering RenaZorb

Nov. 4, 2002

Keryx extends international manufacturing and negotiating rights for KRX-101

Oct. 30, 2002

A-278637: enhanced bladder selectivity and potency as compared to other KCOs

Oct. 29, 2002

FDA accepts Oxytrol NDA for filing

Oct. 29, 2002

FDA accepts Striant NDA for review

Oct. 23, 2002

Small-molecule MC4 receptor agonist with effects on food intake and erectile activity

Oct. 21, 2002

Columbia and Ardana enter European marketing partnership for Striant

Oct. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....